Attached files
file | filename |
---|---|
S-1/A - S-1/A - Inozyme Pharma, Inc. | d919364ds1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption Experts and to the use of our report dated May 8, 2020, except for Note 13(d), as to which the date is July 20, 2020, in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-239648) and related Prospectus of Inozyme Pharma, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
July 20, 2020